Novartis buys Pfizer incontinence drug
October 29, 2003Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …
Look closer – The importance of local opinion leaders
October 29, 2003Sales and Marketing key opinion leaders
There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …
Roche survey shows cancer postcode prescribing continues
October 29, 2003A new UK-wide survey by Roche has shown a third of breast cancer patients who could benefit from its NICE-approved …
Limited lifting of NICE ‘ban’ on Tamiflu
October 29, 2003Sales and Marketing
Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …
The new GP contract : incentives for pharma too
October 29, 2003GP contract, NHS, healthcare
As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …
Betaferon and Avonex in head-to-head MS trial
October 29, 2003Research and Development, Sales and Marketing
Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …
Aventis awards ClinPhone preferred supplier status
October 29, 2003Research and Development
Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …
Do doctors really use the Internet?
October 29, 2003Sales and Marketing doctors, internet
Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …
Zyprexa approved for bipolar disorder
October 29, 2003Sales and Marketing
Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …
New HRT study shows doubling of cancer risk
October 29, 2003Research and Development
A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …
Retaining the talent you recruit
October 29, 2003Business Services recruitment, strategy
The vast majority of people who want to work in the pharma industry have high ideals and wish to be …
Merck expands into US proteomics
October 29, 2003Research and Development
Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …
Shire cuts back ahead of US expansion
October 29, 2003Sales and Marketing
Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …
Genzyme buys SangStat for $600m
October 29, 2003Research and Development
US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …
Pfizer/Pharmacia mega-merger gains final clearance
October 29, 2003Sales and Marketing
The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance …
AstraZeneca prepares Crestor for battle
October 29, 2003Sales and Marketing
AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA approval.Crestor …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
